Thyroid Cancer Trial, Recruiting NCT07419932 Sponsor: Fujian Medical University Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT07419932
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 14 years of age or older at the time of enrollment
  • People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (ECOG score of 0–2)
  • People who have been formally diagnosed with thyroid cancer through laboratory testing of tissue or cell samples, including specific types such as differentiated, medullary, poorly differentiated, or anaplastic thyroid carcinoma
  • People whose thyroid cancer has been classified as locally advanced (a specific stage involving the thyroid and nearby lymph nodes), confirmed by a specialist team of thyroid cancer doctors
  • For people whose cancer has spread to other parts of the body, the treating medical team must have documented that surgery could provide a meaningful benefit
  • People who have at least one tumour that can be measured using standard imaging criteria
  • People whose major organs (such as the heart, liver, and kidneys) are functioning normally
  • People who have provided written agreement to take part in the trial

Who may not be able to join:

  • People who are unwilling to undergo a tumour tissue biopsy or surgery
  • People who have previously had surgery on the thyroid or a major operation in the neck area
  • People who have previously received cancer treatments — including surgery, chemotherapy, radiation therapy, or targeted drug therapy — that may interfere with the current treatment plan
  • People who currently have another active cancer diagnosis
  • People who have other serious ongoing health conditions that are not well controlled, such as diabetes or high blood pressure
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-591-86218065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Medical University
Registry
ClinicalTrials.gov
Start date
23 December 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Radiographic Response; Pathologic Response; Progression-Free Survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov